Volume 6, Issue 3, Pages (September 2007)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 6, Pages (December 2011)
Advertisements

All roads lead to FoxO Cell Metabolism
Volume 2, Issue 3, Pages (September 2005)
Volume 15, Issue 1, Pages (January 2012)
Volume 4, Issue 1, Pages (January 2003)
Volume 3, Issue 5, Pages (May 2006)
Volume 16, Issue 10, Pages (September 2016)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 22, Issue 4, Pages (October 2015)
Volume 10, Issue 4, Pages (October 2009)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 15, Issue 3, Pages (March 2012)
Volume 11, Issue 4, Pages (April 2010)
Volume 12, Issue 4, Pages (October 2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 29, Issue 4, Pages (April 2016)
Volume 15, Issue 5, Pages (May 2012)
Volume 15, Issue 1, Pages (January 2012)
Volume 15, Issue 5, Pages (May 2012)
Volume 18, Issue 6, Pages (December 2013)
Volume 48, Issue 6, Pages (December 2012)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Volume 12, Issue 6, Pages (December 2010)
Volume 10, Issue 1, Pages (July 2009)
Volume 25, Issue 6, Pages e8 (June 2017)
Volume 14, Issue 2, Pages (August 2011)
Volume 7, Issue 2, Pages (February 2008)
Volume 9, Issue 3, Pages (March 2009)
Volume 2, Issue 5, Pages (November 2005)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Volume 7, Issue 2, Pages (February 2008)
Volume 3, Issue 6, Pages (June 2006)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 23, Issue 6, Pages (June 2016)
Volume 137, Issue 4, Pages (May 2009)
Volume 16, Issue 4, Pages (October 2012)
Volume 3, Issue 4, Pages (April 2006)
Volume 9, Issue 5, Pages (May 2009)
Volume 6, Issue 4, Pages (October 2007)
Volume 11, Issue 3, Pages (March 2010)
Volume 8, Issue 4, Pages (October 2008)
Volume 5, Issue 5, Pages (May 2007)
Volume 1, Issue 4, Pages (April 2005)
Volume 15, Issue 3, Pages (March 2012)
Volume 9, Issue 6, Pages (December 2014)
Volume 6, Issue 1, Pages (July 2007)
Joseph T. Rodgers, Wilhelm Haas, Steven P. Gygi, Pere Puigserver 
Volume 14, Issue 4, Pages (October 2011)
Critical role of STAT3 in leptin's metabolic actions
Volume 16, Issue 2, Pages (August 2012)
Prevention of Steatosis by Hepatic JNK1
Volume 15, Issue 6, Pages (June 2012)
Volume 9, Issue 5, Pages (May 2009)
Volume 8, Issue 1, Pages (July 2008)
Volume 8, Issue 5, Pages (November 2008)
Volume 3, Issue 5, Pages (May 2006)
Volume 22, Issue 4, Pages (October 2015)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 5, Issue 6, Pages (June 2007)
Volume 7, Issue 6, Pages (June 2008)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 6, Issue 1, Pages (July 2000)
Volume 6, Issue 4, Pages (October 2007)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Volume 18, Issue 1, Pages (July 2013)
Volume 26, Issue 2, Pages e3 (January 2019)
Presentation transcript:

Volume 6, Issue 3, Pages 208-216 (September 2007) Impaired Regulation of Hepatic Glucose Production in Mice Lacking the Forkhead Transcription Factor Foxo1 in Liver  Michihiro Matsumoto, Alessandro Pocai, Luciano Rossetti, Ronald A. DePinho, Domenico Accili  Cell Metabolism  Volume 6, Issue 3, Pages 208-216 (September 2007) DOI: 10.1016/j.cmet.2007.08.006 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 Generation and Metabolic Features of l-Foxo1 Mice (A and B) Expression of Foxo1 (A) and Foxo3 (B) mRNA in 10-week-old l-Foxo1 (filled bars) and littermate control mice (open bars). n = 4 for each genotype. (C) Western blot analysis of Foxo1 in liver. (D) Blood glucose levels at postnatal day 2. (E) PAS staining of liver sections in l-Foxo1 and littermate controls. One asterisk indicates p < 0.05, two asterisks indicates p < 0.01. Cell Metabolism 2007 6, 208-216DOI: (10.1016/j.cmet.2007.08.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 Metabolic Effects of Hepatic Foxo1 Ablation in Adult Mice (A) Expression of hepatic genes in fasted and fed 16-week-old l-Foxo1 and littermate control mice (n = 6–9 mice per group). (B) Blood glucose levels in 48-hr-fasted animals. ∗ = p < 0.001, control versus l-Foxo1 mice. (C) Pyruvate challenge. (D and E) Intraperitoneal glucose tolerance (D) in 16-week-old; and insulin tolerance tests (E) in 12-week-old l-Foxo1 and littermate controls (n = 7–10 mice per group). (F–K) Glucose clamps. Glucose infusion rates (F), glucose production (G), glucose disappearance (H), glucose cycling (I), glycogenolysis (J), and gluconeogenesis (K) during hyperinsulinemic euglycemic clamps in 10-week-old l-Foxo1 and littermate controls (n = 9 mice per group). l, PAS staining of liver sections and hepatic glycogen content in 14-week-old l-Foxo1 and littermate controls (n = 8 mice per group). All data are presented as means ± SEM. One asterisk indicates p < 0.05, two asterisks p < 0.01. (L and M) Measurements of hepatic glycogen content and PAS staining of liver sections. Cell Metabolism 2007 6, 208-216DOI: (10.1016/j.cmet.2007.08.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 PGC1α-Induced Gluconeogenic and Mitochondrial OXPHOS Gene Expression in Primary Hepatocyte Cultures Prepared from l-Foxo1 or Control Mice After transduction with adenovirus encoding either PGC1α or β-galactosidase, hepatocyte cultures were incubated with or without insulin (100 nM) in serum-free mediun for 24 hr. The difference between control and Foxo1 shRNA is statistically significant at all doses tested (p < 0.001). Cell Metabolism 2007 6, 208-216DOI: (10.1016/j.cmet.2007.08.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 Effects of Loss of Function of Foxo1 on Glucose Production in Primary Hepatocytes (A) Decrease of Foxo1 mRNA (lower panel) and protein (immunoblot) levels following Foxo1 shRNA transduction. (B) Induction of G6pc, Pck1, Ppargc1a, and Igfbp1 by cAMP and/or dexamethasone and inhibition by insulin in Foxo1 knockdown hepatocytes (C: control shRNA adenovirus; F: Foxo1 shRNA adenovirus). The difference between control and Foxo1 shRNA is statistically significant at all doses tested (p < 0.01). (C) Reduction of glucose release into the medium in Foxo1 knockdown hepatocytes. (D) Levels of insulin receptor (Insr), Irs1, and Irs2 mRNA. (E) Tyrosine phosphorylation and protrein amounts of Insr, Irs1, and Irs2, and association of Pi 3-kinase p85 subunit with Irs1 and Irs2. Hepatocytes were treated with insulin, and subjected to immunoprecipitation (IP) and immunoblot (IB) with the indicated antibodies. (F) Induction of G6pc, Pck1, and Ppargc1a by cAMP and inhibition by insulin in Foxo1 knockout hepatocytes. (G) Reduction of glucose release in Foxo1 knockout hepatocytes. One asterisk indicates p < 0.01. Cell Metabolism 2007 6, 208-216DOI: (10.1016/j.cmet.2007.08.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 Hepatic Foxo1 Ablation in Insr−/− Mice (A) Metabolic parameters in WT control, Insr−/− and Insr−/−::l-Foxo1 mice (Dko) (n = 7 mice for each group). (B) Kaplan-Meier plots of Insr−/− (solid line) and Dko mice (dotted line). (C) Appearance of the liver, PAS, and oil red O staining of liver sections in Insr−/− and Dko mice. The liver is outlined for comparison. (D) Hepatic gene expression in fed mice (n = 6–8 mice for each group). Data in (A)–(D) were obtained at postnatal day 2. (E) Metabolic parameters in 14-week-old Dko (filled bars) and littermate controls (open bars) (n = 7 mice for each group). Data are means ± SEM. (F) Necroscopic analyses of 14-week-old Dko and control mice. (G) H&E staining of pancreatic sections demonstrating islet hyperplasia. (H) PAS and oil red O staining of liver sections. Cell Metabolism 2007 6, 208-216DOI: (10.1016/j.cmet.2007.08.006) Copyright © 2007 Elsevier Inc. Terms and Conditions